Patents expiring in 2030

US 7833533

Enhanced antiviral activity against foot and mouth disease

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834037

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7833722

Ligands for G protein-coupled receptor protein and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7834088

Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

Nektar Therapeutics · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7833968

Pharmaceutical compositions for treating or preventing bone conditions

The Regents of the University of California · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7833789

Monocyte cell

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7833972

Proteins and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838253

Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)

The Regents of the University of California · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838511

Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers

The Board of Regents of the University of Texas System · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838571

Photopolymers and use in dental restorative materials

The Regents of the University of Colorado · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838535

Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7837999

Method of increasing muscle mass with IGF-1 fusion polypeptides

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838517

Compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838554

Dihydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838556

Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands

The Board of Regents of the University of Texas System · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838595

Water-soluble polymer alkanals

Nektar Therapeutics · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838691

Palmerolides: methods of preparation and derivatives thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838531

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838289

Assay utilizing multipotent adult stem cells

Regents of the University of Minnesota · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838004

Method of making a partially hydrolyzed fucoidan composition

Sakura Properties, LLC · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838491

Self-assembly and mineralization of peptide-amphiphile nanofibers

Northwestern University · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838216

Human gene related to but distinct from EGF receptor gene

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7838562

Methods of inhibiting vascular permeability and apoptosis

UNIVERSITY OF CONNECTICUT · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842701

Pyrazoloquinolone derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842729

Anti tubercular drug: compositions and methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842819

Derivatives for modulation of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842798

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842717

DNT-maleate and methods of preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842704

Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842686

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842667

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

REGENTIS BIOMATERIALS LTD. · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842706

Pharmaceutical composition

Takeda Pharmaceutical Company Limited · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846973

Chemical process and new crystalline form

Theravance, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846454

Cloned genomes of infectious hepatitis C viruses and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846455

Attenuated chimeric respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846466

Biodegradable scaffolds and uses thereof

Northwestern University · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846690

Cloning of honey bee allergen

PLS-Design GmbH · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846664

Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

The Regents of the University of California · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846675

Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846903

Type II cubic liquid crystal composition

KURARAY CO., LTD. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846907

Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846945

Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846951

Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846895

Selectively targeted antimicrobial peptides and the use thereof

The Regents of the University of California · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846908

RNAi modulation of TGF-beta and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846955

Salt

Argenta Discovery Limited · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846431

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

HALOZYME, INC. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846426

Compositions and methods for treating and preventing cardiomyopathy and heart disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)